Company Overview and News

 
Obsidian Energy: A Leveraged Bet On Oil And Gas Prices

2018-09-20 seekingalpha
The company can't operate at a profit at current oil and gas prices. Despite the operating costs reduction, the situation will not improve for the rest of the year.
BNE OBE BNEFF OWE

 
Torc Oil & Gas: Good But Not The Best

2018-09-16 seekingalpha
The valuation is not attractive enough for me to buy. And for a comparable price, I prefer another similar company.
BNE VREYF WCP BNEFF SPGYF

 
Canadian Drillers Plan Spending Boost

2018-09-05 oilprice
Irina is a writer for the U.S.-based Divergente LLC consulting firm with over a decade of experience writing on the oil and gas industry.
BNE BNEFF

 
Rising oil price will spur drilling by small, intermediate producers, analysts predict

2018-09-04 cbc.ca
Rising oil prices that encouraged more spending by small and intermediate oil and gas companies in Western Canada in the first six months of 2018 are expected to lead drilling budgets to grow even further this fall.
BNE WCP BNEFF SPGYF

 
Bonterra Energy Corp. Confirms Cash Dividend for August 2018 Payable September 28, 2018

2018-09-04 globenewswire
CALGARY, Alberta, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Bonterra Energy Corp. (www.bonterraenergy.com) (TSX:BNE) (“Bonterra” or the “Company”) announces that the August 2018 monthly cash dividend will be $0.10 per share and will be paid on September 28, 2018. The record date for the dividend is September 14, 2018 and the ex-dividend date is September 13, 2018. The dividend is paid monthly and is subject to commodity prices and production levels.
BNE BNEFF

 
Bonterra Energy Corp. Announces Second Quarter 2018 Financial and Operational Results

2018-08-08 globenewswire
CALGARY, Alberta, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Bonterra Energy Corp. (www.bonterraenergy.com) (TSX: BNE) (“Bonterra” or the “Company”) is pleased to announce its operating and financial results as at and for the three and six months ended June 30, 2018. The related unaudited condensed financial statements and notes, as well as management’s discussion and analysis (“MD&A”), are available on SEDAR at www.
BNE BNEFF

 
Bonterra Energy Corp. Confirms Cash Dividend for July 2018 Payable August 31, 2018

2018-08-01 globenewswire
CALGARY, Alberta, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Bonterra Energy Corp. (www.bonterraenergy.com) (TSX:BNE) (“Bonterra” or the “Company”) announces that the July 2018 monthly cash dividend will be $0.10 per share and will be paid on August 31, 2018. The record date for the dividend is August 15, 2018 and the ex-dividend date is August 14, 2018. The dividend is paid monthly and is subject to commodity prices and production levels.
BNE BNEFF

 
Bonterra Energy Corp. Confirms Cash Dividend for June 2018 Payable July 31, 2018

2018-07-03 globenewswire
CALGARY, Alberta, July 03, 2018 (GLOBE NEWSWIRE) -- Bonterra Energy Corp. (www.bonterraenergy.com) (TSX:BNE) (“Bonterra” or the “Company”) announces that the June 2018 monthly cash dividend will be $0.10 per share and will be paid on July 31, 2018. The record date for the dividend is July 16, 2018 and the ex-dividend date is July 13, 2018. The dividend is paid monthly and is subject to commodity prices and production levels.
BNE BNEFF

 
119 Monthly Pay Canadian Dividend Stocks Show 1% To 19% Yields To June 2019

2018-06-02 seekingalpha
Monthly Paying (MoPay) dividend equities make dividend payouts to shareholders twelve times a year instead once, twice, or four times.
CCAOF EBGUF FFN CBL NAF.UN AD ALARF CRIUF BNEFF CHW.DB SOT.UN CJR.B CHW MR.UN AHOTF OSP CNDCF BK CHWWF CGIFF BNE LCS CJREF FNCSF

68
Unknown, Profitable, Oil-Weighted Energy Producer At Deep Discount To NAV And Peers

2018-05-23 seekingalpha - 2
Razor Energy is an oil-weighted energy producer that has increased its production significantly since 2017 while maintaining a strong balance sheet with leverage being well below 2 times.
BTE PGH CJ CRLFF CPG WCP YGR BNEFF VET SGY ZPTAF RRENF YGRAF RRX QTEYF GXOCF QEC TNEYF GENGF ATU CPG BNE RZREF GXO VET IPOOF GXE BTE SPGYF

 
Bonterra Energy Corp. Announces Approval of All Resolutions at Annual General Meeting of Shareholders and Voting Results

2018-05-15 globenewswire
CALGARY, Alberta, May 15, 2018 (GLOBE NEWSWIRE) -- Bonterra Energy Corp. (www.bonterraenergy.com) (TSX:BNE) announced that at its annual general meeting of shareholders held on May 15, 2018, a total of 17,332,310 shares, representing 52.03% of common shares outstanding, were represented in person or by proxy. Shareholders approved all resolutions listed in the management information circular dated April 3, 2018, including the election of each of the five nominees proposed as directors.
BNE BNEFF

10
Construct Your Oil Portfolio: Income Investing

2018-04-18 seekingalpha
This is Part 2 of a three-piece series aiming to take a long, hard look at how to go about building an oil stock portfolio that fits your personality.
BNE HSCSX CJ CRLFF BSM KRP BNEFF FANG

 
Bonterra Energy Corp. Confirms Cash Dividend for March 2018 Payable April 30th, 2018

2018-04-02 globenewswire
CALGARY, Alberta, April 02, 2018 (GLOBE NEWSWIRE) -- Bonterra Energy Corp. (www.bonterraenergy.com) (TSX:BNE) (“Bonterra” or the “Company”) announces that the March 2018 monthly cash dividend will be $0.10 per share and will be paid on April 30th, 2018. The record date for the dividend is April 16th, 2018 and the ex-dividend date is April 13th, 2018. The dividend is paid monthly and is subject to commodity prices and production levels.
BNE BNEFF

17
125 Monthly Pay Dividend SML Equities And 70 Funds Storm In March

2018-03-22 seekingalpha
Contents: 1. US/CDN Stocks @6.5%+ yield (125) 2. Stocks by price upside (30); 3. Closed-End Investment Companies, Exchange-Traded Funds & Notes (CEICs/ETFs/ETNs) @6.5%+ yield (70).
FNNCF CCAOF CBL AD CRIUF ALARF BNEFF ORC SOT.UN CJR.B ECC ECCZ AGNC AHOTF ECCY DGS DVSPF ECCB BNE CJREF ECCA GNL

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to TSX:BNE / Bonterra Energy Corp on message board site Silicon Investor.

Ken Heebner and CGM Focus Fund CGMFX Ken Heebner and CGM Focus Fund CGMFX Ken Heebner and CGM Focus Fund CGMFX Business Wire Falls for April Fools Prank, Sues FBNers Business Wire Falls for April Fools Prank, Sues FBNers Business Wire Falls for April Fools Prank, Sues FBNers
Sibneft, perhaps a new Lukoil Sibneft, perhaps a new Lukoil Sibneft, perhaps a new Lukoil Ben Ezra Weinstein (BNEZ) Ben Ezra Weinstein (BNEZ) Ben Ezra Weinstein (BNEZ)
Global Networks (GBNE) Global Networks (GBNE) Global Networks (GBNE) Bowne u0026 Co (BNE) Bowne u0026 Co (BNE) Bowne u0026 Co (BNE)
BNET/Intermedia Net, Inc. BNET/Intermedia Net, Inc. BNET/Intermedia Net, Inc. BNEZ and PMA; Success in 1999 BNEZ and PMA; Success in 1999 BNEZ and PMA; Success in 1999
BNEZ Coffee Shop BNEZ Coffee Shop BNEZ Coffee Shop BNEZ Facts Thread: Ben Ezra, Weinstein and Company, Inc. BNEZ Facts Thread: Ben Ezra, Weinstein and Company, Inc. BNEZ Facts Thread: Ben Ezra, Weinstein and Company, Inc.